Skip to content
healthcare.dev

Talzenna

NDC 0069-0353, talazoparib, capsule, liquid filled, from Pfizer Laboratories Div Pfizer Inc.

Product NDC
0069-0353
Status
Listed
Labeler
Pfizer Laboratories Div Pfizer Inc
Dosage form
CAPSULE, LIQUID FILLED
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA217439
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0069-0353 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • TALAZOPARIB TOSYLATE.25 mg/1

Pharmacologic classes

Poly(ADP-Ribose) Polymerase Inhibitor [EPC]; Poly(ADP-Ribose) Polymerase Inhibitors [MoA]

Package NDCNDC-11Package
0069-0353-300006903533030 CAPSULE, LIQUID FILLED in 1 BOTTLE (0069-0353-30)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/c6fd147f-a77e-4a0b-9280-e82ecc41b4be

Use it

Look up 0069-0353 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0069-0353 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0069-0353. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.